The drugmaker paused distribution of the drug in June, and has
already recalled a number of lots of the medicine so far.
Pfizer asked wholesalers and distributors on Thursday to stop the
use and distribution of the tablets immediately.
The company said there was no immediate risk to patients
taking Chantix, but advised them to consult with their health care
provider to check the availability of alternative treatments.
[to top of second column]
Chantix was approved by the FDA
in May 2006 as a prescription medication to help
adults aged 18 and over quit smoking and is
typically used for 12 to 24 weeks.
(Reporting by Amruta Khandekar; Editing by
[© 2021 Thomson Reuters. All rights
Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content